BACE1 and Alzheimer disease: The mRNA expression and activity of BACE1 are increased in the brain, CSF, peripheral blood mononuclear cells and plasma of the elderly as well as probable AD and AD patients, suggesting that plasma BACE1 activity may serve as a biomarker for predicting AD [196, 197].